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Summary Hypoxic cells in KHT sarcomas were characterized using fluorescence activated cell sorting based
on the diffusion properties of the fluorochrome Hoechst 33342. Tumour-bearing female C3H/HeJ mice were
injected i.v. with lOjgg-g Hoechst 33342 and the cells derived from the tumours sorted on the basis of their
staining intensities. For each sorted fraction the DNA histogram was evaluated using FCM analysis. The
results indicated that the bright and dim cells were not equally distributed about the cell cycle. For example, a
greater proportion of S phase cells were in the bright subpopulations whereas the dim subpopulations
contained an increased proportion of cells in GV. When the tumours were irradiated with a single dose of
radiation prior to cell sorting, the dim cells survived preferentially. Dose response curves for the 20% most
dim and 20% most bright cells, sorted on the basis of fluorescence intensity, then were determined. The
survival curves of the dim and bright cells were found to have slopes similar to those of KHT cells irradiated
in situ in dead animals or in vitro under fully oxic conditions, respectively. In addition, when KHT sarcoma-
bearing mice were given a 2.5mmolkg-1 dose of misonidazole (MISO) prior to irradiation and cell sorting,
the dim subpopulation was sensitized whereas the bright subpopulation was not. These findings suggest that
(i) compared to well-oxygenated areas, hypoxic regions of KHT tumours contain a smaller percentage of cells
actively proliferating and (ii) Hoechst 33342 sorting may allow the detailed in situ evaluation of agents acting
directly against hypoxic cells in solid tumours.
Since the milestone observations of Thomlinson and Gray in
1955, which suggested that hypoxia might possibly severely
hamper the success of clinical radiotherapy, hypoxic tumour
cells and approaches to eliminating them have dominated
much of experimental radiobiology (Adams, 1977; Guichard
et al., 1980; Fowler, 1985). Similarly, with the mounting
evidence that oxygen-deficient tumour cells may be refrac-
tory to certain clinically active anti-cancer agents (Teicher
et al., 1981; Siemann, 1984; Sartorelli, 1986; Adams &
Stratford, 1986), the role of hypoxia also has received
considerable attention in both the assessment of the effica-
cies of conventional chemotherapeutic agents and in new
agent development (Moore, 1977; Kennedy et al., 1980;
Teicher & Sartorelli, 1980; Teicher et al., 1981). It is clear
that most rodent tumours contain hypoxic cells (for review,
see Moulder & Rockwell, 1984) and the evidence is fairly
convincing that such cells may influence the clinical outcome
in at least some human neoplasias treated by radiotherapy
(Bush et al., 1978; Guichard et al., 1980; Dische et al., 1983;
Overgaard et al., 1986). Consequently, there has been con-
siderable interest in the in situ characteristics of this, with
respect to therapeutic outcome, potentially critical tumour
cell subpopulation. Yet this has been difficult primarily as a
consequence of an inability to isolate or characterize directly
from solid tumours this relatively small subpopulation (typi-
cally 10-20%) of radiobiologically hypoxic cells in the
presence of an overwhelming majority of well oxygenated
tumour cells. Conventional cell proliferation studies, utilizing
the technique of thymidine autoradiography have demon-
strated that both labeling and mitotic index decreased mar-
kedly with increasing distance from blood vessels (Tannock,
1968; Tannock & Steel, 1970). Consistent with these classic
observations we previously used centrifugal elutriation in
conjunction with FCM and cell survival curve analysis to
show that hypoxic cells in the KHT sarcoma were located
primarily in the G1 phase of the cell cycle (Siemann & Keng,
1987). Taken together, these observations imply that hypoxic
cells in tumours demonstrating diffusion limited hypoxia
may be resistant to therapy not only due to their lack of
oxygen but also a consequence of their cell cycle or prolife-
ration state.
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A novel approach, which utilizes fluorescence activated
cell sorting to study hypoxic cells in solid tumours, was
recently developed by researchers at the British Columbia
Cancer Research Centre (Chaplin et al., 1985; Olive et al.,
1985; Chaplin et al., 1986). This technique allows cells to be
sorted on the basis of their proximity to blood vessels by
making use of the diffusion properties of the fluorescent
stain Hoechst 33342. This stain has a very short distribution
half-life after injection and remains bound within cells (Olive
et al., 1985). Olive et al. (1985) and Chaplin et al. (1985,
1986) have utilized this method extensively to study hypoxic
cells in SCCVII tumours. In the present investigations, this
technique was applied to the KHT sarcoma. In particular,
the aim of these studies was to characterize more definitively
and gain a better understanding of the hypoxic cell sub-
population in this solid tumour model.
Materials and methods
Animals and tumour model
The KHT sarcoma (Kallman et al., 1987) was used in all
experiments. KHT cells are passaged in vivo every two weeks
by preparing single cell suspensions from solid tumours using
a mechanical dissociation procedure (Thomson & Rauth,
1974). For experiments, 2 x 105 tumour cells were injected
into the hind limbs of 8-14 week-old female C3H/HeJ mice
obtained from Jackson Laboratories (Bar Habor, Maine).
Tumours were used when they reached a size of 0.5-0.7g.
Irradiation
Unanaesthetized mice were irradiated whole body using a
137CS source operating at a dose rate of 4.75Gymin-1. The
animals breathed air during the irradiation procedure. Imme-
diately after treatment, the tumours were dissociated to
single cell suspensions using a combination of mechanical
and enzymatic (0.2% trypsin plus DNase) dissociation pro-
cedure (Thomson & Rauth, 1974).
Sorting cells on the basis offluorescence intensity
KHT sarcoma-bearing mice were injected i.v. with a
10jg g-1 dose of Hoechst 33342 twenty minutes prior to
irradiation. Immediately following treatment, the mice were
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a killed and the tumours dissociated to single cell suspensions
as described above. Cells were prepared in 4°C phosphate
buffered saline at a concentration of 5 x 106 cells per ml and
sorted according to fluorescence intensity using an EPICS V
flowcytometer (Loeffler et al., 1987). The cells were stirred
and maintained at 4°C during sorting. Laser excitation at
100-150mW, generated from an Argon laser, was used
throughout the experiments. A minimum of 1 x 105 cells was
collected for each sorted fraction.
Sensitizer treatment
MISO was received from Dr Ven Narayanan, Drug Synthe-
sis and Chemistry Branch of the National Cancer Institute.
The sensitizer was dissolved in sterile saline at a concent-
ration of 20mgml-1 and was injected i.p. according to body
weight 30-45min prior to irradiation.
Flow cytometric analysis
For each sorted fraction, FCM analysis was used to deter-
mine the percentage of cells in the G1, S and G2 +M phases
of the cell cycle (Keng et al., 1981; Siemann & Keng, 1986).
Briefly, FCM measurements were made with an EPICS V
dual laser (argon and krypton) flow cytometer (Coulter
Electronics Inc.), using a TERAK 8600 minicomputer for
data storage and analysis. Cells were fixed in 70% ethanol
and stained with mithramycin (1.Omgml-1) according to the
methods of Crissman & Tobey (1974). DNA histograms
were analyzed using the model of Fried & Mandel (1979)
implemented as the 'CCycle' program on the TERAK 8600
system. Previously obtained results using the KHT sarcoma
have demonstrated a close agreement between the estimates
of cells in the various phases of the cell cycle based on FCM
analysis and tritiated thymidine uptake (Keng et al., 1981).
Clonogenic cell survival asay
After sorting, the cells in fractions of differing fluorescence
intensities were counted using a haemocytometer. Various
dilutions were mixed with lethally irradiated cells in 0.2%
agar containing alpha-minimal essential medium supple-
mented with 10% foetal calf serum plated into 24-well
multiwell plates. The plates were maintained in a 5% CO2 in
air atmosphere at 37°C for two weeks. By this time, the
surviving tumour cells formed colonies which were counted
with the aid of a dissecting microscope. For each sort
fraction, survival values were calculated on the basis of the
number of neoplastic cells actually plated as determined
from different counts performed on cytocentrifuge slides
(Siemann et al., 1981).
Results
In the initial experiments tumour-bearing mice were irra-
diated with a single dose of either 10 or 15.5Gy 20min after
Hoechst dye injection. After tumour dissociation, the cells
were sorted on the basis of fluorescence intensity into 5
fractions. Cells from each sort fraction were prepared for
FCM and cytocentrifuge slide analysis and also plated for
clonogenic cell survival.
DNA histograms of cells dispersed from solid KHT
sarcomas and sorted on the basis of fluorescence intensity
are illustrated in Figure 1a-e. Cell suspensions prepared
from KHT sarcomas contain a mixture of both non-
neoplastic infiltrating host cells and neoplastic cells (Siemann
et al., 1981). In untreated tumours, the former typically
represent -40-60% of the total cell population. These host
cells readily can be identified by morphological analysis or
by their diploid DNA content. The latter contrasts with the
near-tetraploid DNA content of neoplastic KHT cells. The
results in Figure I and Table I illustrate that the sort
fractions contained non-neoplastic cells, but not necessarily
in equal proportions. Further, the data in Table I demon-
strate that the percentage of normal host cells determined on
the basis of differential counts was in good agreement with
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Figure 1 DNA histograms measured from cell subpopulations
obtained by flow cytometry following separation on the basis of
Hoechst 33342 fluorescence intensity. The letters (a-e) represent
the cell sort fractions ranging from the 20% most dim cells (a) to
the 20% most bright cells (e).
Table I Host cell distributions in the 20% most dim and 20% most
bright sort fractions sorted on the basis of Hoechst 33342 fluores-
cence intensity
Sort fraction
20%0 most bright
20% most dim
Host cells (%)'
FCM analysis Differential counts
15.4+ 8.1 18.9+4.2
53.3 + 12.4 45.0+8.0
'Data are the mean+s.d. of 5-8 experiments.
the percentage of diploid cells determined using FCM
analysis.
A comparison of the histograms of the sorted cell popula-
tions (Figure 1) further suggested that the cells in the various
fractions were not equally distributed about the cell cycle.
Consequently, FCM analysis was performed on all the sort
fractions. The data show (Figure 2) that the proportion of
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cells in the S phase of the cell cycle (0) increased from
18.9+3.2% in the most dim fraction to 34.2+4.9% in the
most bright. For the same sort fractions, the proportion of
G1 cells (U) decreased from 75.2+7.2 to 51.3+6.8%. G2+M
cells (A) increased from 5.9+2.1% in the dimmest sort
fractions to 14.5+4.3% in the most bright.
Survival of cells in the isolated fractions obtained from
tumours irradiated with 10 or 15.5Gy prior to sorting is
shown in Figure 3. Results presented have been corrected for
the presence of non-neoplastic host cells as determined from
differential counts made of cytocentrifuge slides (Siemann et
al., 1981). The data indicate that for both radiation doses
investigated, radiosensitivity increased with increasing fluor-
escence intensity. Survival of cells from unirradiated tumours
was constant in all the sort fractions (data not shown).
On the basis of these initial results, investigations were
undertaken in which tumour-bearing mice were irradiated
with a range of doses prior to tumour dissociation and cell
sorting. In these experiments, only the 20% most dim and
20% most bright cells obtained by sorting were analyzed in
detail. Host to tumour cell ratio, cell cycle distribution and
clonogenic cell survival were measured in each experiment.
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Cell survival in the isolated cell fractions following tumour
irradiation with doses ranging between 10 and 18Gy are
shown in Figure 4a. All data were again corrected for the
presence of host cells. The results demonstrate that the
brightly fluorescent tumour cells (o) were 2- to 3-fold more
radiosensitive than those in the dimmest cell fraction (0).
The Do values of the most dim and most bright cell
subpopulations were calculated to be 1.25 +0.2Gy and
3.84+0.2Gy, respectively. These values are comparable to
the Do values of KHT sarcoma cells irradiated under fully
aerobic or anoxic conditions (Hill et al., 1979; Siemann &
Kochanski, 1981; Siemann & Keng, 1984; Siemann &
Mulcahy, 1984). Despite the differences in cell cycle distribu-
tions (Figures 1 and 2), the data in Figure 4 implied that the
difference in radiosensitivity between the cells in the brightest
and dimmest sort fractions was predominantly a conse-
quence of a difference in the cellular oxygenation state at the
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Figure 2 Cell cycle distribution of the neoplastic cells in the
same sort fractions as are illustrated in Figure 1. Data shown for
0-20% and 80-100% fractions are the mean+s.d. of 5 individual
experiments.
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Figure 3 Survival of tumour cells in the sorted subpopulations
following in situ irradiation with 10 or 15.5Gy. The mice were
breathing air during the irradiation. All cell survival values were
corrected on the basis of differential counts performed on
cytospin slides (Siemann et al., 1981).
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Figure 4 Clonogenis cell survival in the sort fractions containing
the 20% most dim (-, *) or 20% most bright (0, El) cells
following in situ irradiation. Mice were irradiated with a range of
doses while breathing air in the absence (a) or presence (b) of a
2.5mmolkg-1 dose of MISO. The dashed lines in (b) are
redrawn from (a). Survival values were corrected as in Figure 3.
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time of irradiation. To test this possibility more directly,
additional experiments were carried out in which mice were
given a 2.5mmol kg-1 dose of MISO prior to tumour
irradiation, dissociation and cell sorting. The results (Figure
4b) indicate that the nitroimidazole pre-treatment sensitized
the dimmest cell subpopulation (H), but not the brightest
(r-). In the presence of MISO, survival points from either
subpopulation fell about the line obtained for cells in the
brightest subpopulation after irradiating tumours in the
absence of the sensitizer (Figure 4a).
Discussion
Previous investigations from our laboratories aimed at study-
ing hypoxic cells in solid tumours have utilized centrifugal
elutriation to characterize this potentially relevant tumour
cell subpopulation (Siemann & Keng, 1987). Those studies
demonstrated that hypoxic cells in the KHT sarcoma were
confined primarily to the G1 phase of the cell cycle, although
the presence of hypoxic S and G2+M cells could not be
ruled out entirely. In the present investigations, an alterna-
tive technique for characterizing hypoxic tumour cells in situ
was employed. This method makes use of the diffusion
properties of the fluorescent stain Hoechst 33342. Although
the stain would not be expected to have diffusion character-
istics identical to those of oxygen, it has been shown that
cells staining brightly are located close to blood vessels
whereas cells exhibiting less intense fluorescence are located
further away (Chaplin et al., 1985; Olive et al., 1985).
Consequently, this technique has been used effectively to
evaluate hypoxic cells in both multi-cell spheroids and
SCCVII mouse tumours (Olive et al., 1985; Chaplin et al.,
1985, 1986).
There are currently two models for the occurrence of
hypoxic regions in solid tumours (Brown, 1979; Sutherland
& Franko, 1980). These models differentiate between 'acute'
and 'chronic' hypoxia. In this context, chronic hypoxia refers
to the long considered oxygen diffusion model (Thomlinson
& Gray, 1955) in which hypoxic tumour cells exist at the
limit of the oxygen diffusion distance. In contrast, acute
hypoxia is often considered to be the consequence of tissue
oxygen deficiencies arising when blood vessels collapse
thereby leaving previously well-oxygenated areas in a tumour
suddenly void of oxygen.
The oxygen diffusion limited model of hypoxia advocates
the traditional belief that chronically hypoxic tumour cells,
situated near necrotic regions distant from blood vessels,
have stopped cycling in the G1 phase. This hypothesis is
supported by tritiated thymidine labeling studies of growth
fractions in both spheroids (Sutherland et al., 1971) and
solid tumours (Tannock, 1968; Tannock & Steel, 1970).
Alternatively, if hypoxia were primarily the consequence of
intermittent opening and closing of blood vessels (acute
hypoxia), a fairly uniform distribution of hypoxic cells about
the cell cycle might be expected.
When .Hoechst 33342 is used in situ to isolate cell sub-
populations from solid tumours according to their location
with respect to blood vessels, it is important to recognize
that it may not be correct to assume that the various cell
subpopulations have the same Hoechst 33342 staining pat-
terns. The observed fluorescence intensity in the isolated
fraction may be dependent not only on the diffusion charac-
teristics of the stain but also on the cell subset present. This
was recently most elegantly illustrated by Loeffler et al.
(1987), who used Hoechst 33342 sorting and centrifugal
elutriation to evaluate the fluorescence of host and neo-
plastic cells derived from solid EMT-6 tumours. These
authors found that the fluorescence intensity varied between
cell types and appeared to be related to the cell volume.
In order to determine whether these factors influenced the
subpopulations identified in the various sort fractions in the
present experiments (Figure 2), we also utilized centrifugal
elutriation (Siemann et al., 1981; Keng et al., 1987) to
evaluate independently the host and neoplastic cells derived
from KHT tumours. Cells were stained either in vivo prior to
tumour dissociation and cell separation or in vitro following
tumour dissociation and elutriation. The G2 tumour cells
were found to fluoresce -2-fold more brightly than tumour
cells in the G1 phase; likely due to their being twice as large.
Consequently it is possible that the proportion of G2+M
cells calculated to be in, for example, the 0-20% sort
fraction (Figure 2) may be somewhat of an underestimate
since some of these cells that should have been in this
fraction may actually have appeared in the next (20-40%)
sort fraction. However, it is likely that this factor had only a
relatively minor effect on the observed cell cycle distributions
in the various sort fractions (Figure 2), because the difference
in the fluorescence of the 0-20% fraction and the 20-40%
fraction was >6-fold. The present results therefore indicate
that the bright and dim staining cells were not equally
distributed about the cell cycle. Rather, the proportion of S
cells decreased with distance from the vessels while the
proportion of G1 cells increased. These data are entirely
consistent with our previous results obtained using centrifu-
gal elutriation to isolate hypoxic cells (Siemann & Keng,
1987) and imply that chronic hypoxia is the dominant form
of hypoxia in this tumour model. This conclusion also is
consistent with the data shown in Figure 3 which illustrate
increasing tumour cell killing with increasing fluorescence
intensity (i.e. decreasing distance from the blood supply).
Similar results have been observed previously by Chaplin et
al. (1986) in small SCCVII tumours containing chronically
hypoxic cells.
In addition to the cell cycle distribution differences, the
results illustrated in Figure 1 and Table I demonstrate that
the proportion of diploid non-neoplastic host cells was not
constant in the various sort fractions. The DNA profiles and
cytospin analyses indicate the existence of a larger percent-
age of host cells in the dimmer sort fractions than in those
staining more brightly; suggesting a larger proportion of host
cells in the hypoxic regions of the tumour. The interpretation
assumes that the two cell types (host and neoplastic) have
similar Hoechst 33342 staining patterns. However, similar to
observations made in the EMT-6 tumour model (Loeffler et
al., 1987), when the host and neoplastic cell subpopulations
were stained in vitro with Hoechst 33342 after separation by
centrifugal elutriation, the average fluorescence intensity of
the host cells was 3-4-fold lower than that of the isolated
neoplastic KHT cells. These staining pattern differences
could be due to differences in the cells' size, surface area or a
number of other factors. Irrespective of the mechanism, the
data imply that host cells sorted into a given fraction
according to a particular stain intensity may not be derived
from the same physical location within a tumour as the
neoplastic cells sorted into the same fraction. Consequently,
it is not possible to draw firm conclusions from the present
findings about the distribution of host cells relative to
aerobic or hypoxic KHT tumour cells.
Although significant cell cycle distribution differences
between the bright and dim staining cell populations were
observed (Figure 2), particularly with respect to the S and
G1 cell cycle phases, it is unlikely that these differences had
a major impact on the cell survival illustrated in Figures 3
and 4. This is because in the KHT sarcoma, there is little
difference between the radiation sensitivity of the most
resistant S and G1 cell subpopulations (Siemann & Keng,
1984; Keng et al., 1984) i.e., the cell subpopulations which
dominate the dimmest and brightest sort fractions. However,
when Hoechst 33342 sorting is used to study hypoxic
subpopulations in other tumour models, differences in the
cell cycle distributions in the sorted fractions may need to be
considered when interpreting the results.
When the nitroimidazole MISO was administered to
tumour-bearing mice prior to irradiation, the dimmest
tumour cell sort fraction was radio-sensitized but the
brightest cell fraction was not (Figure 4b). These data
support previous results (Chaplin et al., 1985, 1986; Olive et300 D.W. SIEMANN & P.C. KENG
al., 1985) which indicated that Hoechst 33342 could be used
to sort radiobiologically hypoxic cells directly from solid
tumours or multi-cell spheroids. In addition, these findings
offer direct in situ evidence that MISO sensitizes hypoxic
tumour cells preferentially.
In summary, the present results suggest that the cell
isolation technique based on Hoechst 33342 stain diffusion
may be useful in both the characterization of hypoxic cell
subpopulations in vivo and the evaluation of the efficacy of
therapeutics against oxic and hypoxic tumour cell sub-
populations. The latter may be of particular importance in
(i) mechanistic studies of drug actions and (ii) the develop-
ment of new agents with modes of action directed specifi-
cally (either as radiosensitizers or as cytotoxic agents) against
hypoxic tumour cells.
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